Humana Inc: Form 10-Q for the period ended Mar 31, 2011
Filed with the SEC on May 3, 2011 and accepted by EDGAR at May 3, 2011, 16:43 ET.
Management's discussion and analysis
As filed, 1,516 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(a) None.
(b) N/A
(c) The following table provides information about purchases by us during the three months ended March 31, 2011 of equity securities that are registered by us pursuant to Section 12 of the Exchange Act:
| Period | Total Number of Shares Purchased(1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1)(2) | Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(1) |
|---|---|---|---|---|
| January 2011 | 0 | $0 | 0 | $150,071,119 |
| February 2011 | 0 | 0 | 0 | 150,071,119 |
| March 2011 | 825,000 | 63.73 | 825,000 | 97,512,939 |
| Total | 825,000 | $63.73 | 825,000 | $97,512,939 |
(1) As announced on April 26, 2011, in April 2011, the Board of Directors replaced its previously approved share repurchase authorization of up to $250 million with a new authorization for repurchases of up to $1 billion of our common shares exclusive of shares repurchased in connection with employee stock plans. The new authorization will expire June 30, 2013. Under this share repurchase authorization, shares may be purchased from time to time at prevailing prices in the open market, by block purchases, or in privately-negotiated transactions, subject to certain regulatory restrictions on volume, pricing, and timing. As of May 2, 2011, the remaining authorized amount under the new authorization totaled $1 billion.
(2) Excludes 592,679 shares repurchased in connection with employee stock plans.
Market risk
As filed, 2,080 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Our earnings and financial position are exposed to financial market risk, including those resulting from changes in interest rates.
Interest rate risk also represents a market risk factor affecting our consolidated financial position due to our significant investment portfolio, consisting primarily of fixed maturity securities of investment-grade quality with an average S&P credit rating of AA- at March 31, 2011. Our net unrealized gain position fell $18.9 million from a net unrealized gain position of $196.5 million at December 31, 2010 to a net unrealized gain position of $177.6 million at March 31, 2011. At March 31, 2011, we had gross unrealized losses of $64.6 million on our investment portfolio primarily due to an increase in market interest rates and tighter liquidity conditions in the current markets than when the securities were purchased, and as such, there were no material other-than-temporary impairments during the three months ended March 31, 2011. While we believe that these impairments are temporary and we currently do not have the intent to sell such securities, given the current market conditions and the significant judgments involved, there is a continuing risk that future declines in fair value may occur and material realized losses from sales or other-than-temporary impairments may be recorded in future periods.
Duration is the time-weighted average of the present value of the bond portfolio’s cash flow. Duration is indicative of the relationship between changes in fair value and changes in interest rates, providing a general indication of the sensitivity of the fair values of our fixed maturity securities to changes in interest rates. However, actual fair values may differ significantly from estimates based on duration. The average duration of our investment portfolio, including cash and cash equivalents, was approximately 3.9 years as of March 31, 2011. Based on the duration including cash equivalents, a 1% increase in interest rates would generally decrease the fair value of our securities by approximately $414 million.
Controls and procedures
As filed, 1,257 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Under the supervision and with the participation of our Chief Executive Officer, or CEO, our Chief Financial Officer, or CFO, and our Principal Accounting Officer, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures for the quarter ended March 31, 2011.
Based on our evaluation, our CEO, CFO, and Principal Accounting Officer concluded that our disclosure controls and procedures are effective to provide reasonable assurance that information the Company is required to disclose in its reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, including, without limitation, ensuring that such information is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
There have been no changes in the Company’s internal control over financial reporting during the quarter ended March 31, 2011 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Risk factors
As filed, 1,340 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Except as set forth below, there have been no changes to the risk factors included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2010, filed with the SEC on February 17, 2011, as modified by the changes to those risk factors included in other reports we filed with the SEC subsequent to February 17, 2011:
- On February 25, 2011, the Department of Defense TRICARE Management Activity, or TMA, awarded the TRICARE South Region contract to us. On March 7, 2011, the competing offeror filed a protest of the award with the Government Accountability Office, or GAO. Also on March 7, 2011, as provided in the Federal Acquisition Regulations, TMA issued a stop work order to us in connection with the award. As a result of the award of the TRICARE South Region contract to us, we no longer expect a goodwill impairment to occur during the second half of 2011. Ultimate disposition of the contract award is, however, subject to the resolution of the protest filed by the unsuccessful bidder.
This list of important factors is not intended to be exhaustive, and should be read in conjunction with the more detailed description of these risks that may be found in our reports filed with the SEC from time to time, including our annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2011-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2011-01-01 to 2011-03-31 | $9.19bn | us-gaap:Revenues |
| Selling, general and administrative | 3 months2011-01-01 to 2011-03-31 | $1.26bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2011-01-01 to 2011-03-31 | $524.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2011-01-01 to 2011-03-31 | $27.2m | us-gaap:InterestExpense |
| Income tax | 3 months2011-01-01 to 2011-03-31 | $181.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2011-01-01 to 2011-03-31 | $315.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2011-01-01 to 2011-03-31 | $1.86 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2011-01-01 to 2011-03-31 | $1.88 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2011-01-01 to 2011-03-31 | 169,534,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2011-01-01 to 2011-03-31 | $795.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2011-01-01 to 2011-03-31 | $70.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2011-01-01 to 2011-03-31 | $88.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2011-03-31 | $1.76bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2011-03-31 | $11.10bn | us-gaap:AssetsCurrent |
| Total assets | At period end2011-03-31 | $17.16bn | us-gaap:Assets |
| Current liabilities | At period end2011-03-31 | $6.36bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2011-03-31 | $9.93bn | us-gaap:Liabilities |
| Long-term debt | At period end2011-03-31 | $1.67bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2011-03-31 | $7.23bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2011-03-31 | 168,394,377 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001193125-11-124060. Last ingested by Listed: Nov 13, 2026, 14:11 ET. Listed shows no prices and gives no investment advice.